PLI application for KSMs and APIs
Department of Pharmaceuticals had issued guidelines for the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) in the Country on 29th October 2020. Applications were invited under the Scheme which have already been appraised and selected.- PLI application for KSMs and APIs-PLI in food processing
The Department further invites applications from eligible applicants under the Scheme
for the left over slots/quantity for the following eligible products:-
| Target Segment | Name of Eligible Product | Minimum Annual Production Capacity as per Scheme Guidelines (in MT) | Shortfall in Minimum Annual Production Capacity (in MT) | Maximum no. of applicants to be selected |
| Key Fermentation based KSMs/Drug Intermediates | Erythromycin Thiocynate (TIOC) | 800 | 1,600 MT | 2 |
| 7 – ACA | 1000 | 1,000 MT | 1 | |
| Fermentation based niche KSMs/Drug Intermediates /APIs | Neomycin | 80 | 160 MT | 2 |
| Gentamycin | 40 | 80 MT | 2 | |
| Vitamin B1 | 200 | 200 MT | 1 | |
| Clindamycin Bas | 60 | 120 MT | 2 | |
| Streptomycin | 50 | 100 MT | 2 | |
| Tetracycline | 200 | 400 MT | 2 | |
| Key Chemical Synthesis based KSMs/Drug Intermediates | Dicyandiamide (DCDA) | 8000 | 32,000 MT | 4 |
| 2-MNI | 800 | 3200 MT | 4 |
The last date for filing of the application is 45 days from the issuance of the Notice.
